Free Trial

United Therapeutics (UTHR) Stock Forecast & Price Target

United Therapeutics logo
$572.20 -9.02 (-1.55%)
Closing price 04:00 PM Eastern
Extended Trading
$568.74 -3.47 (-0.61%)
As of 05:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

United Therapeutics - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
3
Buy
10

Based on 13 Wall Street analysts who have issued ratings for United Therapeutics in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 13 analysts, 3 have given a hold rating, and 10 have given a buy rating for UTHR.

Consensus Price Target

$601.50
5.12% Upside
According to the 13 analysts' twelve-month price targets for United Therapeutics, the average price target is $601.50. The highest price target for UTHR is $705.00, while the lowest price target for UTHR is $330.00. The average price target represents a forecasted upside of 5.12% from the current price of $572.20.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for UTHR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for United Therapeutics and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UTHR Analyst Ratings Over Time

TypeCurrent Forecast
5/5/25 to 5/5/26
1 Month Ago
4/5/25 to 4/5/26
3 Months Ago
2/4/25 to 2/4/26
1 Year Ago
5/5/24 to 5/5/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
9 Buy rating(s)
8 Buy rating(s)
8 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$601.50$586.00$509.50$392.00
Forecasted Upside5.12% Upside3.75% Upside5.58% Upside31.24% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

UTHR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

UTHR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

United Therapeutics Stock vs. The Competition

TypeUnited TherapeuticsMedical CompaniesS&P 500
Consensus Rating Score
2.77
2.30
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside3.64% Upside912.71% Upside15.29% Upside
News Sentiment Rating
Positive News

See Recent UTHR News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
4/10/2026
Morgan Stanley logo
Morgan Stanley
3 of 5 stars
Terence Flynn
Terence Flynn
4 of 5 stars
Boost TargetEqual Weight$471.00 ➝ $519.00-8.79%
4/10/2026 Initiated CoverageOutperform$700.00+21.79%
3/31/2026
HC Wainwright logo
HC Wainwright
3 of 5 stars
Andrew S.
Andrew S.
Not Rated
Boost TargetBuy$600.00 ➝ $660.00+13.06%
3/31/2026Boost TargetEqual Weight$486.00 ➝ $575.00-2.57%
3/31/2026Boost TargetNeutral$569.00 ➝ $626.00+6.40%
3/30/2026Boost TargetBuy$575.00 ➝ $660.00+11.36%
3/12/2026Boost TargetOverweight$525.00 ➝ $625.00+16.78%
3/5/2026Boost TargetBuy$655.00 ➝ $705.00+44.64%
3/2/2026Reiterated RatingBuy
2/26/2026Boost TargetOutperform$575.00 ➝ $600.00+19.98%
2/26/2026Boost TargetOutperform$587.00 ➝ $643.00+28.95%
12/29/2025 Reiterated RatingBuy (B)
7/8/2025Lower TargetOverweight$350.00 ➝ $330.00+10.88%
11/1/2024 Boost TargetNeutral$243.00 ➝ $302.00-19.66%
10/31/2024Boost TargetBuy$319.00 ➝ $344.00-7.87%
10/31/2024 Boost TargetBuy$360.00 ➝ $400.00+10.45%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 05:24 PM ET.


UTHR Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for United Therapeutics is $601.50, with a high forecast of $705.00 and a low forecast of $330.00.

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for United Therapeutics in the last twelve months. There are currently 3 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" UTHR shares.

According to analysts, United Therapeutics's stock has a predicted upside of 5.12% based on their 12-month stock forecasts.

Analysts like United Therapeutics more than other "medical" companies. The consensus rating for United Therapeutics is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how UTHR compares to other companies.


This page (NASDAQ:UTHR) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners